Vascular Endothelial Growth Factor Receptor 2 Antagonist drugs
1 medication in the FDA established pharmacologic class “Vascular Endothelial Growth Factor Receptor 2 Antagonist”.
| Drug | Type | NDC products |
|---|---|---|
| Cyramza ramucirumab | Rx | 2 |
1 medication in the FDA established pharmacologic class “Vascular Endothelial Growth Factor Receptor 2 Antagonist”.
| Drug | Type | NDC products |
|---|---|---|
| Cyramza ramucirumab | Rx | 2 |